XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Payments (Tables)
9 Months Ended
Sep. 30, 2021
Summary of Company's Stock Option Activity

The following is a summary of the Company’s stock option activity during the nine months ended September 30, 2021:

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

Aggregate

 

 

 

 

 

 

 

Remaining

 

 

Weighted

 

 

Intrinsic

 

 

 

Number of

 

 

Contractual

 

 

Average

 

 

Value

 

 

 

Stock Options

 

 

Life (in years)

 

 

Exercise Price

 

 

(in thousands)

 

Outstanding as of December 31, 2020

 

 

113,558

 

 

7.75

 

 

$

159.33

 

 

$

 

Granted

 

 

554,615

 

 

 

 

 

 

 

15.05

 

 

 

 

Forfeited/Cancelled

 

 

(26,807

)

 

 

 

 

 

 

64.55

 

 

 

 

Exercised

 

 

(214

)

 

 

 

 

 

 

10.50

 

 

 

1

 

Outstanding as of September 30, 2021

 

 

641,152

 

 

 

9.24

 

 

$

38.54

 

 

$

 

Exercisable as of September 30, 2021

 

 

271,433

 

 

 

8.72

 

 

$

66.81

 

 

$

 

 

Summary of Company's Restricted Stock Award Activity

The following is a summary of the Company’s RSU award activity for the nine months ended September 30, 2021:

 

 

Number of RSUs

 

 

Weighted Average Grant Date Fair Value per Unit

 

Outstanding as of December 31, 2020

 

 

168

 

 

$

13.20

 

Granted

 

 

9,871

 

 

 

15.41

 

Forfeited

 

 

(2,668

)

 

 

14.50

 

Settled

 

 

(3,428

)

 

 

15.56

 

Outstanding as of September 30, 2021

 

 

3,943

 

 

$

15.81

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Stock-Based Compensation Expense is Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss

Stock-based compensation expense is classified in the Company’s condensed consolidated statements of operations and comprehensive loss as follows (amounts in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

$

156

 

 

$

245

 

 

$

540

 

 

$

727

 

Cost of sales

 

 

2

 

 

 

 

 

 

5

 

 

 

(1

)

Selling, general and administrative

 

 

582

 

 

 

205

 

 

 

3,351

 

 

 

1,295

 

Total

 

$

740

 

 

$

450

 

 

$

3,896

 

 

$

2,021

 

Employee and Director Stock Options  
Estimation Using Black-Scholes Option Pricing Model With Following Weighted Average Assumptions

 

The weighted average grant date fair value of employee and director stock options granted for the nine months ended September 30, 2021 was $10.67 per option and the grant date fair values of these stock options were estimated using the Black-Scholes option pricing model using the following weighted average assumptions:

 

 

Nine Months Ended September 30, 2021

 

Stock price

 

$

15.14

 

Exercise price

 

$

15.05

 

Expected term

 

7.04 years

 

Expected volatility

 

 

78.27

%

Risk-free interest rate

 

 

1.18

%

Dividend rate

 

 

0.00

%